Cambridge Investment Research Advisors, Inc.
Position in PEN — Penumbra Inc
CIK 1419186
FAIRFIELD, IA
Position in PEN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$349,851
-$33,028 QoQ
Shares Held
1,108
-5.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#302
of 446 holders
Holding Since
Dec 2020
10 quarters on record
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $94,085,440 across 27 Medical Devices names. PEN ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
299,079 | $27,138,428 | |
| 2 | SYK |
Stryker Corp
|
73,172 | $23,037,472 | |
| 3 | MDT |
Medtronic plc
|
241,056 | $18,857,810 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
82,290 | $5,267,382 | |
| 5 | EW |
Edwards Lifesciences Corp
|
45,749 | $4,138,454 | |
| 6 | DXCM |
Dexcom Inc
|
45,009 | $3,031,356 | |
| 7 | BSX |
Boston Scientific Corp
|
51,066 | $2,179,496 | |
| 8 | STE |
STERIS plc
|
7,965 | $1,677,190 |
All Filings in PEN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,851 | 1,108 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $382,879 | 1,166 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $328,631 | 1,057 | Shares | Sole | 2026-02-05 | |
| 2025-06-30 | $2,491,877 | 9,710 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,614,467 | 9,777 | Shares | Sole | 2025-04-22 | |
| 2023-06-30 | $1,265,452 | 3,678 | Shares | Sole | 2023-07-13 | |
| 2021-12-31 | $705,370 | 2,455 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $647,861 | 2,431 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $656,921 | 2,397 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $218,575 | 1,249 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||